✦ LIBER ✦

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

✍ Scribed by Trey Sunderland; Nadeem Mirza; Karen T. Putnam; Gary Linker; Deepa Bhupali; Rob Durham; Holly Soares; Lida Kimmel; David Friedman; Judy Bergeson; Gyorgy Csako; James A. Levy; John J. Bartko; Robert M. Cohen

Book ID: 119196497
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 273 KB
Volume: 56
Category: Article
ISSN: 0006-3223
DOI: 10.1016/j.biopsych.2004.07.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CSF β-amyloid 1–42 and tau in Tunisian p

CSF β-amyloid 1–42 and tau in Tunisian patients with Alzheimer's disease: The effect of APOE ɛ4 allele

✍ Mohamed Ali Smach; Bassem Charfeddine; Turkia Lammouchi; Imed Harrabi; Leila Ben 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Amyloid beta 1–42 and tau in the cerebro

Amyloid beta 1–42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer′s disease

✍ Shea, Yat Fung; Chu, Leung-wing; Mok, Ming-yee Maggie; Lam, Man-Fai 📂 Article 📅 2014 🏛 Wichtig Editore 🌐 English ⚖ 156 KB

Basic and Clinical Studies on the Measur

Basic and Clinical Studies on the Measurement of β-amyloid(1–42) in Cerebrospinal Fluid as a Diagnostic Marker for Alzheimer's Disease and Related Disorders: Multi Center Study in Japan

✍ Masatoshi Takeda; Toshihisa Tanaka; Hiroyuki Arai; Hidetada Sasaki; Mikio Shoji; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

The urokinase-type plasminogen activator

The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-ε4 non-carriers in the Italian Alzheimer’s disease population and does not affect the plasma Aβ(1–42) level

✍ Marzia Pesaresi; Sara Batelli; Francesca Prato; Letizia Polito; Carlo Lovati; El 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 168 KB